Global Quality Standard for Identification and Management of Severe Asthma

Introduction Severe asthma is a debilitating, life-threatening disease associated with substantial global morbidity, mortality, and health care resource utilization. Patients may not receive guideline-directed medical care for severe asthma. Moreover, viable precision-based assessment tools and newe...

Full description

Saved in:
Bibliographic Details
Published in:Advances in therapy 2020-09, Vol.37 (9), p.3645-3659
Main Authors: Haughney, John, Winders, Tonya A., Holmes, Steve, Chanez, Pascal, Saul, Hannah, Menzies-Gow, Andrew
Format: Article
Language:English
Subjects:
Anti-Asthmatic Agents - standards
Anti-Asthmatic Agents - therapeutic use
Asthma - therapy
Cardiology
Commentary
Endocrinology
Health technology assessment
Human health and pathology
Humans
Internal Medicine
Life Sciences
Medicine
Medicine & Public Health
Oncology
Patient-Centered Care - standards
Pharmacology/Toxicology
Practice Guidelines as Topic
Precision Medicine - standards
Quality of Life
Referral and Consultation
Rheumatology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Introduction Severe asthma is a debilitating, life-threatening disease associated with substantial global morbidity, mortality, and health care resource utilization. Patients may not receive guideline-directed medical care for severe asthma. Moreover, viable precision-based assessment tools and newer preventive therapies that can reduce the frequency of exacerbations and associated functional impact are underused. As a result, high rates of poorly controlled severe asthma persist, and patient health-related quality of life suffers. Methods In 2019, the Improve Access to Better Care Task Force of the PRECISION Steering Committee set out to develop a global template on quality standards for severe asthma care to support improved access to and delivery of quality care. This Quality Standard is grounded in the vast body of published evidence available for severe asthma care, published clinical guidelines (i.e., from the Global Initiative for Asthma in 2019 and the European Respiratory Society/American Thoracic Society in 2014), and the 2018 PRECISION-supported Charter to Improve Patient Care in Severe Asthma . Results The Quality Standard developed emphasizes four key elements aimed at optimizing clinical care and outcomes in severe asthma: (1) organization of services, (2) timely identification and referral for suspected severe asthma, (3) specialized assessment and management of severe asthma to optimize outcomes, and (4) patient-centric care and shared decision-making that is reflective of the patient’s expectations, priorities, and values. Four key Quality Statements are provided, along with quality metrics and strategies for local adaptation to optimize implementation. Conclusion This Global Quality Standard is intended to mobilize policymakers, health care providers, and patient advocacy groups to build consensus on the definition and expectations of quality care in severe asthma, to promote patient-centric care, to identify gaps in care and areas for improvement, and systematically implement improvement measures and outcomes and to reduce the burden of illness for patients with severe asthma. Plain Language Summary Although only 10% of patients with asthma have severe disease, these patients use up to half of all health care resources used to treat asthma. For the patient, severe asthma is associated with substantial morbidity, increased risk of death, and poor quality of life. Effective treatments for severe asthma are available, yet access to these tr
ISSN:0741-238X
1865-8652
DOI:10.1007/s12325-020-01450-7